Naraghi MA, et al
Primary and secondary outcomes Primary outcomes The primary efficacy endpoints of the study encompassed the alterations noted in the DAS28-CRP, in conjunction with scores derived from the MHAQ and VAS, assessed from baseline to the conclusion of the 12-week treatment duration
Retatrutide reverses the pro-fibrotic metabolomic profile in adipose tissue Metabolomic analysis revealed a distinct pro-fibrotic metabolic signature in the eWAT of HFD-fed mice compared to the NCD group
Clostridium butyricum nourishes the gut lining, promotes healthy inflammatory markers and supports healthy barrier function
Peptides vs Minoxidil, Hormone-Targeting Treatments, PRP, and Other Options Peptides generally have less established human evidence than several conventional hair-loss treatments, but they may support different parts of a broader plan
Liver Health Non-alcoholic fatty liver disease (NAFLD) often improves significantly with semaglutide treatment